Supply of Cryoprecipitated AHF (Antihemophilic Factor)

The contract seeks the supply of cryoprecipitated antihemophilic factor units that meet full FDA compliance standards, requiring strict adherence to traceability protocols, accurate labeling, and verifiable freedom from contamination. All units must be manufactured, handled, and transported under validated cold chain conditions to preserve integrity and efficacy. The deliverables are intended for use in clinical settings where precise hemostatic support is critical, ensuring patient safety and regulatory conformity throughout the product lifecycle. This subcontract is issued by the Department of Veterans Affairs through its 260-NETWORK Contract Office 20, with performance required in Seattle, Washington, under the NAICS code 325414 for pharmaceutical and medicinal manufacturing. Responses are due by May 22, 2026, at 4:00 a.m. Eastern Time, and the solicitation remains open for qualified vendors to submit proposals aligned with the specified quality and logistical requirements. There is no set-aside designation specified, and all bidders must demonstrate capability to meet the stringent regulatory and operational criteria outlined by the government.